Real-World Outcomes of Patients With Symptomatic Obstructive HCM Treated With Mavacamten
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JACC: Heart Failure
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Real-World Experience and 36-Week Outcomes of Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten
JACC Heart Fail 2024 Jun 01;12(6)1123-1125, N Reza, A Dubey, T Carattini, A Marzolf, N Hornsby, A de Feria, N Mahmud, P Schuler, AT OwensFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.